Cargando…
Interstitial Lung Disease Secondary to Long-Term Nitrofurantoin Use
Patient: Male, 88-year-old Final Diagnosis: Interstitial lung disease Symptoms: Chronic dyspnea Medication: Nitrofurantoin Clinical Procedure: None Specialty: Pulmonology OBJECTIVE: Adverse events of drug therapy BACKGROUND: Interstitial lung disease, also known as diffuse parenchymal lung disease,...
Autores principales: | Chin, Andrew J., Rashid, Saadri, Gharibeh, Tarek R., Kibbe, Peter S., Wynbrandt, Jonathan H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161918/ https://www.ncbi.nlm.nih.gov/pubmed/32238797 http://dx.doi.org/10.12659/AJCR.920386 |
Ejemplares similares
-
Nitrofurantoin induced interstitial lung disease
por: Naidu, G. D., et al.
Publicado: (2014) -
Nitrofurantoin: Interstitial lung disease: case report
Publicado: (2021) -
Concomitant Nitrofurantoin-Induced Autoimmune Hepatitis and Interstitial Lung Disease
por: Carvalho de Matos, Andreia, et al.
Publicado: (2021) -
Unrecognized Interstitial Lung Disease as a Result of Chronic Nitrofurantoin Use
por: Rambaran, Kerry Anne, et al.
Publicado: (2016) -
Nitrofurantoin-Associated Acute Granulomatous Interstitial
Nephritis
por: Anupama, B. K., et al.
Publicado: (2021)